Free Trial

ALX Oncology (ALXO) Insider Trading & Ownership

ALX Oncology logo
$1.62 +0.14 (+9.46%)
(As of 12/20/2024 05:45 PM ET)

ALX Oncology (NASDAQ:ALXO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
33.40%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$198,624.00
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$1.85 M
Get ALXO Insider Trade Alerts

Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ALXO Insider Buying and Selling by Quarter

ALX Oncology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2024Rekha HemrajaniDirectorBuy30,000$1.55$46,500.00  
8/14/2024Shelly PintoCAOSell564$2.58$1,455.12  
8/14/2024Sophia RandolphInsiderSell1,365$2.58$3,521.70  
7/11/2024Jaume PonsInsiderSell20,000$7.90$158,000.00  
7/5/2024Shelly PintoCAOSell1,823$5.50$10,026.50  
7/1/2024Shelly PintoCAOSell1,373$5.82$7,990.86  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

7/1/2024Sophia RandolphInsiderSell3,273$5.82$19,048.86  
6/13/2024Peter S GarciaCFOBuy12,000$8.53$102,360.00  
6/4/2024Jaume PonsInsiderSell20,000$8.43$168,600.00  
5/13/2024Sophia RandolphInsiderSell12,000$15.94$191,280.00  
5/6/2024Jaume PonsInsiderSell20,000$15.92$318,400.00  
4/16/2024Jaume PonsInsiderSell50,000$14.20$710,000.00  
4/4/2024Jaume PonsInsiderSell20,000$11.15$223,000.00  
3/14/2024Jason LettmannCEOBuy4,400$11.31$49,764.00  
1/4/2024Shelly PintoCAOSell2,717$13.60$36,951.20  
(Data available from 1/1/2013 forward)

ALXO Insider Trading Activity - Frequently Asked Questions

The list of insiders at ALX Oncology includes Jason Lettmann, Jaume Pons, Peter S Garcia, Rekha Hemrajani, Shelly Pinto, and Sophia Randolph. Learn more on insiders at ALXO.

33.40% of ALX Oncology stock is owned by insiders. Learn more on ALXO's insider holdings.

The following insiders have purchased ALXO shares in the last 24 months: Jason Lettmann ($49,764.00), Peter S Garcia ($102,360.00), and Rekha Hemrajani ($46,500.00).

Insiders have purchased a total of 46,400 ALXO shares in the last 24 months for a total of $198,624.00 bought.

The following insiders have sold ALXO shares in the last 24 months: Jaume Pons ($1,601,546.72), Peter S Garcia ($6,510.58), Shelly Pinto ($107,733.52), and Sophia Randolph ($225,631.26).

Insiders have sold a total of 166,626 ALX Oncology shares in the last 24 months for a total of $1,941,422.08 sold.

ALX Oncology Key Executives

  • Dr. Corey S. Goodman Ph.D. (Age 72)
    Executive Chairman
    Compensation: $84k
  • Mr. Jason W. LettmannMr. Jason W. Lettmann (Age 47)
    CEO & Director
    Compensation: $60.5k
  • Dr. Jaume Pons Ph.D. (Age 57)
    Founder, President, Director & Chief Scientific Officer
    Compensation: $856.29k
  • Mr. Peter S. Garcia M.B.A.Mr. Peter S. Garcia M.B.A. (Age 62)
    Chief Financial Officer
    Compensation: $631.11k
  • Dr. Sophia Randolph M.D. (Age 56)
    Ph.D., Chief Medical Officer & Director
    Compensation: $637.24k
  • Dr. Michael Chang Ph.D.
    Vice President of Operations
  • Ms. Shelly Pinto (Age 47)
    Senior VP of Finance & Chief Accounting Officer
    Compensation: $508.26k
    3 recent trades
  • Dr. Christopher Byrd J.D.
    Ph.D., General Counsel
  • Dr. Athanasios Tsiatis M.D.
    Senior Vice President of Clinical Development
  • Dr. Lin Yeong-Liang M.D.
    M.S., Senior Vice President of Drug Safety & Pharmacovigilance


This page (NASDAQ:ALXO) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners